Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Life Sciences | for Life Sciences

We describe Sensyne Health’s role as a “docking station” between the providers of data and those who need it to guide medical innovation, and we are proud to provide this connection ethically and efficiently while protecting public trust in how their data is used.

Through our NHS partnerships, we have access to large quantities of rich, anonymised patient data. This includes information on prescriptions, diagnoses, imaging, pathology and outcomes. When combined with our proprietary machine learning methods, we can provide actionable insights for the life sciences industry.

Sensyne are progressing AI pharmacologic discovery programmes in four therapeutic areas:

Autoimmune disease

Neurodegenerative disease

Cardiovascular disease

Immunological disease and cancer

How we work

Undertake paid-for research for pharmaceutical companies

Clinical trials support and analysis

Real world outcomes for marketed medicines

Take an economic interest in the pharmaceutical product

Partner with us

Find out more about how we partner with the life sciences industry and understand how we could partner with you.

Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451

Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives

Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

We describe Sensyne Health’s role as a “docking station” between the providers of data and those who need it to guide medical innovation, and we are proud to provide this connection ethically and efficiently while protecting public trust in how their data is used.

Sensyne are progressing AI pharmacologic discovery programmes in four therapeutic areas:

Autoimmune disease

Neurodegenerative disease

Cardiovascular disease

Immunological disease and cancer

How we work

Partner with us

Find out more about how we partner with the life sciences industry and understand how we could partner with you.

CONTACT

Investor Enquiries

FOLLOW US

EXPLORE

Healthcare

LEGAL

EXPLORE

Healthcare

Follow US

Legal

Contact

Investor Enquiries